Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Share News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amphion Convertible Promissory Notes, Macaleer Terms Extended (ALLISS)

Tue, 05th Jan 2016 08:21

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday revealed an extension to the terms of its convertible promissory notes and of the promissory notes held by its former chairman.

The company, which develops medical and technology businesses, said the extension follows a meeting of the holders of its unsecured convertible promissory notes 2008-2015 on December 30.

"After due consideration, it was resolved by a large majority of the note holders that the terms of the notes be amended such that the due date for settlement be February 28, 2016 rather than December 31, 2015," Amphion said.

Talks about reaching a resolution in the longer term are expected to be concluded by the end of February, it said.

In addition, the company said it has agreed in principle to replace the USD3.3 million of notes payable to James Macaleer, former Amphion chairman, and the USD3.3 million payable to the RJM Amphion Trust, a trust set up for the benefit of his children.

The notes will be replaced with an issue of promissory notes that will mature on December 31, 2016, rather than December 31, 2015.

The rate of interest on the notes remains at 7.0%. The new notes contain provisions for early repayment.

However, no payment will be made on the new notes unless the company repays in full its existing loan facility.

Shares in Amphion were up 4.5% at 4.05 pence on Tuesday morning.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
10 Sep 2015 09:23

WINNERS & LOSERS SUMMARY: Dixons And Next Up But Morrisons Sinks

Read more
10 Sep 2015 07:12

Amphion Innovations' DataTern Gets Favourable Patent Dispute Ruling

Read more
3 Sep 2015 09:42

WINNERS & LOSERS SUMMARY: M&A Speculation And Upgrade Boost Morrisons

Read more
3 Sep 2015 07:46

Amphion Innovations Sees "Dramatic Rise" In Value On Motif Bio Float

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
5 Jun 2015 10:59

LONDON MIDDAY BRIEFING: Vodafone In Asset Swap Talks With Liberty

Read more
5 Jun 2015 10:27

WINNERS & LOSERS: Halfords Rides Higher As Sales Hit GBP1 Billion

Read more
5 Jun 2015 07:11

Amphion Innovations Raises GBP1.5 Million In Discounted Issue (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
7 Apr 2015 08:01

Amphion Innovations Gets GBP580,842 From Exercised Warrants (ALLISS)

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more
24 Mar 2015 15:41

Amphion Issues 1.3 Million Shares At GBP0.0266 To YA Global Master (ALLISS)

Read more
20 Mar 2015 12:20

LONDON MIDDAY BRIEFING: TSB Banking To Go The Way Of Abbey National

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.